7ALE | pdb_00007ale

Crystal structure of human PAICS in complex with inhibitor 69


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.95 Å
  • R-Value Free: 
    0.261 (Depositor), 0.266 (DCC) 
  • R-Value Work: 
    0.225 (Depositor), 0.230 (DCC) 
  • R-Value Observed: 
    0.227 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7ALE

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Cellular and biochemical validation of a potent PAICS inhibitor

Marttila, P.Skerlova, J.Unterlass, J.Jemth, A.-S.Henriksson, M.Wakchaure, P.Grube, M.Warpman Berglund, U.Homan, E.Stenmark, P.Helleday, T.

To be published.

Macromolecule Content 

  • Total Structure Weight: 96.21 kDa 
  • Atom Count: 6,650 
  • Modeled Residue Count: 838 
  • Deposited Residue Count: 850 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Multifunctional protein ADE2
A, B
425Homo sapiensMutation(s): 0 
Gene Names: PAICSADE2AIRCPAIS
EC: 6.3.2.6 (PDB Primary Data), 4.1.1.21 (PDB Primary Data)
UniProt & NIH Common Fund Data Resources
Find proteins for P22234 (Homo sapiens)
Explore P22234 
Go to UniProtKB:  P22234
PHAROS:  P22234
GTEx:  ENSG00000128050 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP22234
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
RLK
(Subject of Investigation/LOI)

Query on RLK



Download:Ideal Coordinates CCD File
C [auth A],
E [auth B]
2-azanyl-~{N}-[2-bromanyl-5-[4-[3-(dimethylamino)propylsulfonyl]piperazin-1-yl]phenyl]-1,3-oxazole-4-carboxamide
C19 H27 Br N6 O4 S
GTJMWLKWMPRNKA-UHFFFAOYSA-N
OK8
(Subject of Investigation/LOI)

Query on OK8



Download:Ideal Coordinates CCD File
D [auth A],
F [auth B]
(2~{S})-2-[[5-azanyl-1-[(2~{R},3~{R},4~{S},5~{R})-3,4-bis(oxidanyl)-5-(phosphonooxymethyl)oxolan-2-yl]imidazol-4-yl]car bonylamino]butanedioic acid
C13 H19 N4 O12 P
NAQGHJTUZRHGAC-ZZZDFHIKSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
RLK BindingDB:  7ALE IC50: 10 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.95 Å
  • R-Value Free:  0.261 (Depositor), 0.266 (DCC) 
  • R-Value Work:  0.225 (Depositor), 0.230 (DCC) 
  • R-Value Observed: 0.227 (Depositor) 
Space Group: I 2 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 60.772α = 90
b = 152.44β = 90
c = 222.755γ = 90
Software Package:
Software NamePurpose
XSCALEdata scaling
MOLREPphasing
REFMACrefinement
PDB_EXTRACTdata extraction
XDSdata reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Swedish Research CouncilSweden2015-00162
Swedish Research CouncilSweden2018-03406
European Research Council (ERC)European UnionTAROX-695376
European Regional Development FundEuropean UnionCZ.02.2.69/0.0/0.0/16_027/0008477

Revision History  (Full details and data files)

  • Version 1.0: 2022-04-20
    Type: Initial release
  • Version 1.1: 2024-01-31
    Changes: Data collection, Refinement description